A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan

NCT00421811 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: ADH-1
DRUG: melphalan

Sponsor

Adherex Technologies, Inc.